Related Experiment Video

Updated: May 18, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

Hypoxia and gerosuppression: the mTOR saga continues

Olga V Leontieva1, Mikhail V Blagosklonny

  • 1Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA.

Cell Cycle (Georgetown, Tex.)
|September 19, 2012
PubMed

Insights

Hypoxia suppresses cellular aging (geroconversion) by inhibiting the mTOR pathway, but this effect is cell-type specific and depends on intact p53 function.

Area of Science:

  • Cellular senescence
  • Molecular biology
  • Aging research

Background:

  • Cellular senescence is a state of irreversible growth arrest.
  • Growth-promoting pathways like mTOR drive the conversion of cell cycle arrest into senescence (geroconversion).
  • Hypoxia (low oxygen) was previously shown to suppress geroconversion.

Purpose of the Study:

  • To investigate the role of mTOR inhibition in hypoxia-induced suppression of geroconversion.
  • To determine if hypoxia's effects on geroconversion are cell-type specific.
  • To explore the interplay between p53, hypoxia, and mTOR in regulating senescence.

Main Methods:

  • Cellular models of senescence induction.
  • Manipulation of the mTOR pathway (e.g., TSC2 depletion).
  • Assessment of geroconversion under hypoxic conditions.
  • Analysis of cancer cell lines with varying resistance to mTOR inhibition.

Main Results:

  • Hypoxia-induced suppression of geroconversion requires mTOR inhibition.
  • Depletion of TSC2 abolished both mTOR inhibition and gerosuppression by hypoxia.
  • Hypoxia failed to suppress geroconversion in p53-proficient cancer cells resistant to mTOR inhibition.
  • The effects of hypoxia on the oxygen-sensing mTOR pathway and geroconversion are cell type-specific.

Conclusions:

  • mTOR inhibition is a critical mediator of hypoxia's gerosuppressive effects in certain cell types.
  • The interplay between hypoxia, mTOR, and p53 dictates the cellular response to senescence.
  • Hypoxia's impact on aging pathways is context-dependent and varies across cell types.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...